Facing the Shadow: Community discussions on diversity, race, and privilege in psychedelics psychedelics/entheogens
Rachel Hope was one of the first participants treated for chronic, treatment resistant PTSD in the MAPS-sponsored clinical trial that used MDMA-assisted psychotherapy. Rachel will speak on her message of personal life-saving transformation from decades of crippling trauma, failed therapies and prescribed drugs to a sustained, drug free recovery through MDMA-assisted therapy, ecstatic dance, and public activism. The three MDMA-assisted psychotherapy sessions set the stage for Rachel to be her own healer.
This is the inaugural event kicking of AWARE PROJECT SAN DIEGO: Rethinking Psychedelics. It is also a FUNdraiser for the revolutionary work that the Multidisciplinary Association for Psychedelic Studies (MAPS.org) is doing to lift the stigma about psychedelic compounds and advance scientific and therapeutic research.